Not every high or low glucose reading is an emergency, but specific numbers signal immediate danger. Here's exactly where the clinical lines are drawn and what to do when you cross them.
A dangerous blood sugar level is any reading that places you at immediate risk of acute metabolic complications. For most adults, a blood glucose below 54 mg/dL (3.0 mmol/L) constitutes serious hypoglycemia requiring rapid treatment, while a reading persistently above 250 mg/dL (13.9 mmol/L) with elevated ketones signals diabetic ketoacidosis risk, and any level above 600 mg/dL (33.3 mmol/L) can trigger hyperosmolar hyperglycemic state — both are life-threatening emergencies.[1]
What Makes a Blood Sugar Level Dangerous?
A dangerous blood sugar level is not simply a number outside the normal fasting range of 70–100 mg/dL (3.9–5.6 mmol/L). Danger arises when glucose reaches a concentration that overwhelms the body's compensatory mechanisms — either because there is too little glucose to fuel the brain and vital organs (hypoglycemia) or because the blood has become toxic from sustained hyperglycemia with metabolic derangement.
Two distinct clinical danger zones exist: the low end and the high end. Each has its own pathophysiology, symptoms, and time window for intervention. Approximately 11.6% of the U.S. population — 38.4 million people — have diabetes,[2] and each year roughly 1 in 5 of them will experience a severe hypoglycemic or hyperglycemic episode requiring emergency medical attention.[3]
The body maintains blood glucose within a narrow band through a tightly regulated interplay of insulin, glucagon, and stress hormones. When that regulation fails — whether due to medication mismatch, illness, dietary factors, or disease progression — the numbers that follow matter because they predict specific, preventable complications.
The Clinical Thresholds: By the Numbers
Medical organizations, including the American Diabetes Association (ADA) and the Endocrine Society, define danger zones based on outcomes data from large population studies. The table below summarizes the thresholds that clinicians use to determine when a reading requires immediate action.
| Category | Glucose Range | Clinical Significance | Action Required |
|---|---|---|---|
| Severe hypoglycemia | < 54 mg/dL (3.0 mmol/L) | Neuroglycopenic symptoms; cognitive impairment; seizure risk | Immediate oral glucose (15 g) or IV dextrose if unconscious |
| Mild hypoglycemia | 54–69 mg/dL (3.0–3.8 mmol/L) | Autonomic symptoms (shakiness, sweating, palpitations) | Treat with fast-acting carbs; recheck in 15 minutes |
| Normal fasting | 70–99 mg/dL (3.9–5.5 mmol/L) | No metabolic stress; adequate fuel delivery | None |
| Elevated (prediabetes) | 100–125 mg/dL (5.6–6.9 mmol/L) | Impaired fasting glucose; increased cardiovascular risk | Lifestyle intervention; re-screen annually |
| Hyperglycemia (diabetes) | ≥ 126 mg/dL (7.0 mmol/L) fasting | Diagnostic threshold for diabetes; chronic end-organ risk | Confirm with repeat testing; initiate management |
| High hyperglycemia | 250–400 mg/dL (13.9–22.2 mmol/L) | Risk of ketoacidosis (type 1) or HHS (type 2); osmotic diuresis | Check ketones; seek medical guidance |
| Severe hyperglycemia / HHS zone | > 600 mg/dL (33.3 mmol/L) | Hyperosmolar hyperglycemic state; profound dehydration; coma | Emergency department — IV fluids and insulin required |
These thresholds are not arbitrary. The 54 mg/dL cutoff, for instance, was adopted by the ADA and the International Hypoglycaemia Study Group because below that level, counterregulatory hormone responses fail and cognitive function deteriorates measurably.[1] On the high end, the 600 mg/dL threshold for hyperosmolar hyperglycemic state (HHS) is based on the serum osmolality level at which stupor and coma become statistically likely — roughly 320–330 mOsm/kg, which corresponds to a glucose of about 600 mg/dL in the absence of significant ketones.[4]
The danger threshold for diabetic ketoacidosis (DKA) is lower than for HHS — typically around 250 mg/dL (13.9 mmol/L) when accompanied by moderate-to-large ketones and metabolic acidosis. DKA can develop within hours, while HHS evolves over days. Both are medical emergencies, but their onset speeds differ.[5]
What Drives Blood Sugar Into Dangerous Territory?
Understanding why glucose veers into dangerous zones is essential for prevention. The root causes differ significantly between low and high extremes, though medication errors bridge both categories.
Too much insulin or oral hypoglycemic medication
The most common cause of severe hypoglycemia is a mismatch between insulin dose and carbohydrate intake or activity level. Long-acting sulfonylureas (e.g., glipizide, glyburide) carry a particularly high risk of prolonged hypoglycemia in older adults or those with kidney impairment. The CDC estimates that hypoglycemia accounts for over 100,000 emergency department visits annually among insulin-treated patients.[3]
Missed or delayed meals
Skipping a meal after taking rapid-acting insulin or sulfonylureas can drop glucose precipitously. Alcohol consumption — especially on an empty stomach — further impairs hepatic gluconeogenesis, extending hypoglycemia risk for 8–12 hours after drinking. Anyone on insulin or insulin secretagogues should never skip meals after taking their medication.
Illness and infection
Any acute illness — respiratory infection, urinary tract infection, gastroenteritis — triggers the release of counterregulatory hormones (cortisol, epinephrine, growth hormone) that raise blood glucose. In type 1 diabetes, this stress response can rapidly tip into DKA if insulin doses are not adjusted upward. This is why the "sick-day rules" (frequent glucose and ketone monitoring, increased basal insulin) are critical.
Insulin omission or pump failure
In people with type 1 diabetes, missing even a single dose of basal insulin or experiencing an insulin pump occlusion can lead to DKA within 4–6 hours because there is essentially no endogenous insulin reserve. The ADA recommends that all insulin pump users have a backup plan (injectable long-acting insulin) and access to ketone testing supplies.[5]
Corticosteroid therapy
Steroids (prednisone, dexamethasone, hydrocortisone) are potent inducers of insulin resistance and can push glucose well above 300 mg/dL even in people without prior diabetes. In patients with preexisting diabetes, steroid doses as low as 10 mg of prednisone daily often require insulin dose increases of 50–100% to maintain target glucose levels. The hyperglycemia from steroids typically resolves after the taper is complete.
Intense or unplanned exercise
Exercise has a glucose-lowering effect that can persist for up to 24 hours due to increased insulin sensitivity and muscle glucose uptake. For individuals on insulin or sulfonylureas, unplanned high-intensity or prolonged exercise can cause delayed hypoglycemia — sometimes occurring 6–12 hours after the activity, particularly overnight. Pre-exercise carbohydrate snacking and dose reduction are standard preventive strategies.
Recognizing the Warning Signs
Dangerous blood sugar levels produce distinct symptom clusters. Recognizing them early — before the patient loses the ability to self-treat — is the difference between a resolved episode and an ER visit.
Hypoglycemia symptoms (typically below 70 mg/dL)
Hyperglycemia symptoms (typically above 250 mg/dL)
Call emergency services if someone with hypoglycemia is unconscious, seizing, or cannot swallow — do not attempt to give oral food or liquid. For hyperglycemia, seek emergency care if the person is vomiting, has deep rapid breathing, is confused, or has a blood glucose reading above 600 mg/dL (33.3 mmol/L) regardless of symptoms.
Emergency Response Protocols
When a dangerous blood sugar level is confirmed by glucometer, time matters. The response differs depending on whether the reading is dangerously low or dangerously high.
Responding to severe hypoglycemia (< 54 mg/dL)
Responding to severe hyperglycemia (≥ 250 mg/dL with symptoms, or any reading > 600 mg/dL)
Every person with diabetes who uses insulin should have a current glucagon kit (nasal or injectable) accessible at home and carried when traveling. Family members and coworkers should be trained in its use. The ADA recommends that insulin-treated individuals also carry glucose tablets or gel at all times.[1]
What Happens if Left Untreated
Prolonged exposure to a dangerous blood sugar level — in either direction — leads to measurable, often irreversible damage. The complications are not theoretical: they are the reason hospitals admit people with glucose emergencies.
Prolonged severe hypoglycemia deprives the brain of its primary fuel. After 30–60 minutes of glucose below 30 mg/dL (1.7 mmol/L), neuronal energy failure sets in, leading to cerebral edema, permanent cognitive deficits, and in the worst cases, brain death. Hypoglycemia-induced cardiac arrhythmias — particularly prolonged QT intervals — are an under-recognized cause of sudden death in adults with diabetes.[6]
Diabetic ketoacidosis (DKA) causes a metabolic acidosis that the body cannot buffer indefinitely. Severe acidosis (pH < 7.0) impairs cardiac contractility, causes vasodilation and hypotension, and can trigger acute kidney injury. Cerebral edema, though more common in children, occurs in 0.5–1% of adult DKA cases and carries a mortality rate of 20–30% if not recognized early.[5]
Hyperosmolar hyperglycemic state (HHS) produces profound dehydration — typical fluid deficits are 8–12 liters. The extreme hyperosmolality pulls water out of brain cells, leading to altered mental status that can progress to coma. HHS carries a mortality rate of 5–15%, significantly higher than DKA, largely because it tends to occur in older adults with multiple comorbidities.[4]
How to Prevent Dangerous Readings
Prevention is the most effective strategy and rests on four pillars: monitoring, medication management, sick-day planning, and structured follow-up.
Continuous glucose monitoring (CGM) has dramatically reduced the frequency of severe hypoglycemic events. Real-time CGM systems with low-glucose alerts can warn users when glucose is trending below 70 mg/dL, providing a 15–30 minute window to intervene before the person becomes symptomatic. The ADA recommends CGM for all individuals with type 1 diabetes and for insulin-treated type 2 patients at high risk for hypoglycemia.[1]
Structured insulin dose adjustments — especially for basal insulin — reduce both high and low extremes. The simplest preventive strategy for many patients is to transition from sliding-scale rapid-acting insulin alone to a basal-bolus regimen, which more closely mimics physiologic insulin secretion and reduces the likelihood of both hypoglycemia and extreme hyperglycemia.
Sick-day plans should be reviewed at every diabetes visit. The plan should specify: how often to check glucose (every 2–4 hours), how often to check ketones, what fluid to consume, how to adjust insulin doses (typically 10–20% increase in basal insulin during illness), and under what circumstances to go to the emergency department. The CDC emphasizes that inpatient admissions for DKA are preventable in roughly 50% of cases with adequate sick-day education.[7]
Annual hypoglycemia awareness assessment using the Gold score or Clarke questionnaire helps identify people with impaired awareness of hypoglycemia — a condition where the autonomic warning symptoms are blunted, putting them at 6-fold higher risk for severe hypoglycemic events. These individuals benefit from structured education programs (e.g., BGAT, DAFNE) and liberalized glucose targets.[1]
The strongest predictor of a future dangerous blood sugar episode is a past episode. Anyone who has experienced severe hypoglycemia or DKA should have their treatment regimen reviewed within 2 weeks — not just counseled — because the underlying pattern of medication dosing or behavioral factors must be explicitly addressed. A review of insulin-to-carbohydrate ratios, basal rates, and sick-day protocols reduces recurrence risk by 40–60%.[6]
Frequently Asked Questions
Is 200 mg/dL a dangerous blood sugar level?
A fasting or random glucose of 200 mg/dL (11.1 mmol/L) is diagnostic of diabetes and requires medical management, but it is not typically an immediate emergency unless symptoms of DKA or HHS are present or the level is rising rapidly. Sustained levels above 200 mg/dL over weeks to months cause microvascular damage to the eyes, kidneys, and nerves. The acute danger threshold for DKA risk starts around 250 mg/dL (13.9 mmol/L) when ketones are present.[5]
Can stress or illness cause a dangerous blood sugar level in someone without diabetes?
Yes. Critical illness — sepsis, myocardial infarction, stroke, major surgery, or severe trauma — can produce stress hyperglycemia even in people with no prior diabetes. A glucose above 180 mg/dL (10.0 mmol/L) in hospitalized patients is associated with worse outcomes, and levels consistently above 300 mg/dL (16.7 mmol/L) may require insulin therapy regardless of diabetes status. In patients without diabetes, stress hyperglycemia usually resolves once the underlying illness is treated.[8]
What is the "rule of 15" for low blood sugar?
The rule of 15 is the standard approach to treating mild-to-moderate hypoglycemia: consume 15 grams of fast-acting carbohydrate, wait 15 minutes, then recheck your blood glucose. If it is still below 70 mg/dL (3.9 mmol/L), repeat the 15 grams. Do not overtreat — taking 30–40 grams of carbohydrate when 15 grams would suffice often causes rebound hyperglycemia, which then requires additional correction and perpetuates glucose variability.[1]
At what blood sugar level should I go to the ER?
Go to the emergency department if: (1) your blood glucose is below 54 mg/dL (3.0 mmol/L) and glucagon is unavailable or you are unable to keep food/drink down; (2) your glucose remains above 400 mg/dL (22.2 mmol/L) after 4 hours of home treatment; (3) you have moderate-to-large urine or blood ketones; (4) you are vomiting, have deep rapid breathing, are confused, or are unresponsive. Any glucose above 600 mg/dL (33.3 mmol/L) warrants an ER evaluation regardless of symptoms.[4][5]
Can you die from a blood sugar level that is too high?
Yes. Both DKA and HHS can be fatal if untreated. DKA mortality in the U.S. is approximately 0.5–2% in the general adult population, but rises to 5–10% in those over age 65 or with concurrent critical illness. HHS carries a mortality of 5–15%. The primary causes of death are cerebral edema, acute kidney injury, arrhythmias from electrolyte disturbances, and refractory shock. Early treatment with IV fluids, insulin, and electrolyte monitoring dramatically reduces mortality.[4][5]
Does a high blood sugar level always cause symptoms?
No. Many people with type 2 diabetes can have glucose levels in the 200–300 mg/dL range for days or weeks without noticing obvious symptoms because the onset is gradual and the osmotic diuresis is subtle. This is why routine monitoring is essential — relying on symptoms alone leads to delayed recognition of dangerous levels. Conversely, some individuals with type 1 diabetes develop DKA symptoms at glucose levels as low as 250 mg/dL, while others tolerate higher levels before symptom onset.
- A blood glucose below 54 mg/dL (3.0 mmol/L) or persistently above 250 mg/dL (13.9 mmol/L) with ketones is a medical emergency.
- Severe hypoglycemia causes cognitive impairment, seizures, and cardiac arrhythmias — treat immediately with 15 g of fast-acting carbohydrate or glucagon if unconscious.
- Diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS) are life-threatening complications of severe hyperglycemia that require hospital treatment with IV fluids and insulin.
- Continuous glucose monitoring with low-glucose alerts significantly reduces the risk of severe hypoglycemia.
- Every person who uses insulin should have a glucagon kit and a written sick-day plan reviewed annually.
- The strongest predictor of a future dangerous episode is a past episode — prompt medication review after any event reduces recurrence by 40–60%.
- American Diabetes Association — Standards of Care in Diabetes — 2025 (Diabetes Care, Volume 48, Supplement 1, January 2025). Hypoglycemia definition and treatment recommendations, Section 6.
- Centers for Disease Control and Prevention — National Diabetes Statistics Report, 2024. Estimates of diabetes and prediabetes prevalence in the United States.
- Centers for Disease Control and Prevention — Hypoglycemia-Related Emergency Department Visits and Hospitalizations Among Insulin-Treated Adults, 2022.
- American Diabetes Association — Hyperosmolar Hyperglycemic State in Adults: A Consensus Statement, 2023. Threshold definitions and mortality data.
- American Diabetes Association — Management of Diabetic Ketoacidosis in Adults: 2024 Update. Diagnostic criteria, cerebral edema risk, and treatment protocols.
- Endocrine Society — Clinical Practice Guideline: Hypoglycemia Management in Diabetes, 2023. Cardiac risks and recurrence prevention.
- Centers for Disease Control and Prevention — Sick-Day Management for People with Diabetes, 2023. Preventable hospitalization data and education recommendations.
- American College of Physicians — Management of Inpatient Hyperglycemia and Stress Hyperglycemia, 2024. Thresholds and insulin therapy guidance.
